Overall, in our series, 44% (12/27) of all FLT3-ITD-mutated AML and only 10% (6/59) of co-mutated (NPM1m/FLT3m), underwent allo-SCT in their CR1. Here, FLT3 is linked to acute myeloid leukemia.